Moreover, we observed that antibodies against integrins, PKC inhibitor (staurosporine), and siRNA targeted at PKC can inhibit hypochlorite-oxidized HDL induced breast cancer cell invasion and adhesion to HUVEC and ECM. This evidence concerns the gene PRRT2 and breast carcinoma.